{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:11:06Z","timestamp":1792631466950,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00011-015-0896-8","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T04:55:32Z","timestamp":1448427332000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis"],"prefix":"10.1007","volume":"65","author":[{"given":"Puneet","family":"Dixit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Kumar","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep Singh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"896_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","volume":"59","author":"Transverse Myelitis Consortium Working Group","year":"2002","unstructured":"Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59:499\u2013505.","journal-title":"Neurology"},{"key":"896_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000149975.39201.0b","volume":"11","author":"AI Kaplin","year":"2005","unstructured":"Kaplin AI, Krishnan C, Deshpande DM, Pardo CA, Kerr DA. Diagnosis and management of acute myelopathies. Neurologist. 2005;11:2\u201318.","journal-title":"Neurologist"},{"key":"896_CR3","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2741\/1351","volume":"9","author":"C Krishnan","year":"2004","unstructured":"Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci. 2004;9:1483\u201399.","journal-title":"Front Biosci"},{"key":"896_CR4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/0028-3886.51278","volume":"57","author":"L Pandit","year":"2009","unstructured":"Pandit L. Transverse myelitis spectrum disorders. Neurol India. 2009;57:126\u201333.","journal-title":"Neurol India"},{"key":"896_CR5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/B978-0-444-52001-2.00027-3","volume":"122","author":"BAC Cree","year":"2014","unstructured":"Cree BAC. Acute inflammatory myelopathies. Handb Clin Neurol. 2014;122:613\u201367.","journal-title":"Handb Clin Neurol"},{"key":"896_CR6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","volume":"16","author":"A Uzawa","year":"2010","unstructured":"Uzawa A, Mori M, Arai K, Sato Y, Hayakawa S, Masuda S, Taniguchi J, Kuwabara S. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler. 2010;16:1443\u201352.","journal-title":"Mult Scler"},{"key":"896_CR7","doi-asserted-by":"crossref","first-page":"e72399","DOI":"10.1371\/journal.pone.0072399","volume":"8","author":"A Wullschleger","year":"2013","unstructured":"Wullschleger A, Kapina V, Molnarfi N, Courvoisier DS, Seebach JD, Santiago-Raber ML, Hochstrasser DF, Lalive PH. Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases. PLoS ONE. 2013;8:e72399.","journal-title":"PLoS ONE"},{"key":"896_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1750-3639.1994.tb00825.x","volume":"4","author":"AM Romanic","year":"1994","unstructured":"Romanic AM, Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 1994;4:145\u201356.","journal-title":"Brain Pathol"},{"key":"896_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/glia.10108","volume":"39","author":"GA Rosenberg","year":"2002","unstructured":"Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002;39:279\u201391.","journal-title":"Glia"},{"key":"896_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp-2013-305907","volume":"85","author":"A Tasaki","year":"2014","unstructured":"Tasaki A, Shimizu F, Sano Y, Fujisawa M, Takahashi T, Haruki H, Abe M, Koga M, Kanda T. Autocrine MMP-2\/9 secretion increases the BBB permeability in neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2014;85:419\u201330.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"896_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1191\/135248506ms1260oa","volume":"12","author":"J Bruna","year":"2006","unstructured":"Bruna J, Mart\u00ednez-Y\u00e9lamos S, Mart\u00ednez-Y\u00e9lamos A, Rubio F, Arbizu T. Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler. 2006;12:169\u201373.","journal-title":"Mult Scler"},{"key":"896_CR12","author":"MJ Hofer","year":"2015","unstructured":"Hofer MJ, Campbell IL. Immunoinflammatory diseases of the central nervous system\u2014the tale of two cytokines. Br J Pharmacol. 2015. doi: 10.1111\/bph.13175 .","journal-title":"Br J Pharmacol"},{"key":"896_CR13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10875-012-9780-2","volume":"33","author":"UC Linhares","year":"2013","unstructured":"Linhares UC, Schiavoni PB, Barros PO, Kasahara TM, Teixeira B, Ferreira TB, Alvarenga R, Hygino J, Vieira MM, Bittencourt VC, Andrade RM, Andrade AF, Bento CA. The ex vivo production of IL-6 and IL-21 by CD4\u00a0+\u00a0T cells is directly associated with neurological disability in neuromyelitis optica patients. J Clin Immunol. 2013;33:179\u201389.","journal-title":"J Clin Immunol"},{"key":"896_CR14","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI25141","volume":"115","author":"AI Kaplin","year":"2005","unstructured":"Kaplin AI, Deshpande DM, Scott E, Krishnan C, Carmen JS, Shats I, et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Investig. 2005;115:2731\u201341.","journal-title":"J Clin Investig"},{"key":"896_CR15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","volume":"82","author":"M Araki","year":"2014","unstructured":"Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M, Miyake S, Aranami T, Yamamura T. Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology. 2014;82:1302\u20136.","journal-title":"Neurology"},{"key":"896_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.04.009","volume":"236","author":"T Hosokawa","year":"2011","unstructured":"Hosokawa T, Nakajima H, Doi Y, Sugino M, Kimura F, Hanafusa T, Takahashi T. Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood\u2013brain barrier. J Neuroimmunol. 2011;236:81\u20136.","journal-title":"J Neuroimmunol"},{"key":"896_CR17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/brain\/124.3.493","volume":"124","author":"RN Mandler","year":"2001","unstructured":"Mandler RN, Dencoff JD, Midani F, Ford CC, Ahmed W, Rosenberg GA. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic\u2019s neuromyelitis optica. Brain. 2001;124:493\u20138.","journal-title":"Brain"},{"key":"896_CR18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2008.02.008","volume":"196","author":"JJ Graber","year":"2008","unstructured":"Graber JJ, Allie SR, Mullen KM, Jones MV, Wang T, Krishnan C, et al. Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol. 2008;196:124\u201332.","journal-title":"J Neuroimmunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-015-0896-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-015-0896-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-015-0896-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T13:47:55Z","timestamp":1558532875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-015-0896-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1007\/s00011-015-0896-8","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}